Wojciech Szczeklik, Ilona Mitka, Ilona Nowak, Bozena Seczyńiska, Aurelia Sega, Wojciech Wegrzyn, Wiesław Królikowski
{"title":"[Plasmapheresis in intensive therapy unit].","authors":"Wojciech Szczeklik, Ilona Mitka, Ilona Nowak, Bozena Seczyńiska, Aurelia Sega, Wojciech Wegrzyn, Wiesław Królikowski","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Plasmapheresis or therapeutic plasma exchange is a procedure designed to deplete the body of blood plasma without blood cells. Whole blood is removed from the body, the plasma is separated from the cells, and the cells are suspended in saline before being returned to the patient. The procedure is used to remove excess antibodies, immunoglobulins, or cytokines from the blood in various clinical situations. The particles removed should be adequately large (>15 kDa) and have a relatively long half-life. The volume of removed plasma should be based on body weight and haematocrit, and in an adult patient be in range of 2.5-2.7 litres (30-40 mL kg(-1)). To remove 90% of a harmful substance, four to five exchanges are necessary. In the review, several modes of plasmapheresis are described. The most common indications for plasmapheresis in patients treated in an ITU are: thrombotic thrombocytopenic purpura, Waldenström macroglobulinemia, Guillain-Barre syndrome, chronic inflammatory poliradiculopathy, myasthenia gravis, or Lambert-Eaton syndrome.The procedure is safe, and complications are rare and not serious.</p>","PeriodicalId":88221,"journal":{"name":"Anestezjologia intensywna terapia","volume":"42 2","pages":"100-6"},"PeriodicalIF":0.0000,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anestezjologia intensywna terapia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Plasmapheresis or therapeutic plasma exchange is a procedure designed to deplete the body of blood plasma without blood cells. Whole blood is removed from the body, the plasma is separated from the cells, and the cells are suspended in saline before being returned to the patient. The procedure is used to remove excess antibodies, immunoglobulins, or cytokines from the blood in various clinical situations. The particles removed should be adequately large (>15 kDa) and have a relatively long half-life. The volume of removed plasma should be based on body weight and haematocrit, and in an adult patient be in range of 2.5-2.7 litres (30-40 mL kg(-1)). To remove 90% of a harmful substance, four to five exchanges are necessary. In the review, several modes of plasmapheresis are described. The most common indications for plasmapheresis in patients treated in an ITU are: thrombotic thrombocytopenic purpura, Waldenström macroglobulinemia, Guillain-Barre syndrome, chronic inflammatory poliradiculopathy, myasthenia gravis, or Lambert-Eaton syndrome.The procedure is safe, and complications are rare and not serious.
血浆置换或治疗性血浆置换是一种旨在消耗体内没有血细胞的血浆的方法。全血从体内取出,血浆从细胞中分离出来,细胞在返回给病人之前悬浮在生理盐水中。在各种临床情况下,该程序用于从血液中去除多余的抗体、免疫球蛋白或细胞因子。去除的颗粒应足够大(>15 kDa),并具有相对较长的半衰期。血浆移除量应根据体重和红细胞压积而定,成人患者移除量应在2.5-2.7升(30-40 mL kg)。要去除90%的有害物质,需要4到5次交换。本文介绍了血浆置换的几种模式。在国际电联治疗的患者中,血浆置换最常见的适应症是:血栓性血小板减少性紫癜、Waldenström巨球蛋白血症、格林-巴利综合征、慢性炎症性神经根多变性、重症肌无力或兰伯特-伊顿综合征。手术是安全的,并发症很少,也不严重。